Lanevis secures FDA Rare Disease Innovation Hub Support contract

This is an approximately 2.5-year contract to provide support for the Rare Disease Innovation Hub for the Food and Drug Administration (FDA).

Awardee Name: LANEVIS, L.L.C
Total Contract Value: $1,478,036.00
Action Obligation: $498,100.00
Department Name: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Funding Agency: FOOD AND DRUG ADMINISTRATION
Number of Bidders: 1
Award ID: 75F40126C00223
Set Aside Used: 8(a) Sole Source